Log in to save to my catalogue

Genome-wide association study on pharmacological outcomes of musculoskeletal pain in UK Biobank

Genome-wide association study on pharmacological outcomes of musculoskeletal pain in UK Biobank

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2852630004

Genome-wide association study on pharmacological outcomes of musculoskeletal pain in UK Biobank

About this item

Full title

Genome-wide association study on pharmacological outcomes of musculoskeletal pain in UK Biobank

Publisher

London: Nature Publishing Group UK

Journal title

The pharmacogenomics journal, 2023-11, Vol.23 (6), p.161-168

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The pharmacological management of musculoskeletal pain starts with NSAIDs, followed by weak or strong opioids until the pain is under control. However, the treatment outcome is usually unsatisfying due to inter-individual differences. To investigate the genetic component of treatment outcome differences, we performed a genome-wide association study...

Alternative Titles

Full title

Genome-wide association study on pharmacological outcomes of musculoskeletal pain in UK Biobank

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2852630004

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2852630004

Other Identifiers

ISSN

1470-269X

E-ISSN

1473-1150

DOI

10.1038/s41397-023-00314-x

How to access this item